In the last few years there has been more research devoted to CAM.
However, there still remain many obstacles for CAM to be integrated into cancer treatment,
especially lung cancer.
The lack of resources (plants) to produce these herbal remedies could result in inadequate supply
for the potentially high demand.
The technology required for plant extraction and mixture preparation is another hurdle in
establishing an adequate supply.
Another obstacle is the lack of.
Study                   Medication                Study  Design             Sample    Size              Control  (Chemo    therapy  alone)    Results
Chen    YZ,   Li ZD,    Sheng-mai,       Gu-jin   Randomized       control  n=61                        Navelbine  plus  cisplatin            48.5%   survival rate compared   to
Gao   F,  Zhang    Y,   Granule                   study                                                                                       32.2%      survival   in    control
Sun  H, et al. [15]                                                                                                                           subjects
Lin H, Li DR  [16]      Shenqi-Fuzheng            Randomized       control  n=232                       Navelbine     plus    cisplatin   or  Improved     quality  of   life* in
study                                                 paclitaxel plus cisplatin             experimental   arm
Xu    ZY,   Jin   CJ,   Kangliuzeng        xiao,  Randomized       control  n=121                       Navelbine  plus  cisplatin            Improved    quality of life** and a
Zhou    CC,    Wang     Feiyanning                study                                                                                       trend  toward  prolonged   survival
ZQ,  Zhou  WD,  et al.                                                                                                                        time  in experimental  arm
[17]
Tian JH,  Liu LS, Shi   Fiji Recipe               Randomized       control  n=70                        Vinorelbine    plus   cisplatin   or  Improved     quality  of   life* in
ZM,     Zhou      ZY,                             study                                                 gemcitabine   plus cisplatin          regards    to   side   effects   of
Wang   L [18]                                                                                                                                 chemotherapy      in experimental
arm
Yamamoto           K,   Shakuyaku-kanzo-to        Randomized       control  n=10                        Pacltitaxel plus carboplatin          Decreased     adverse   effects  of
Hoshiai  H,  Noda   K                             study                                                                                       chemotherapy-    induced  myalgia
[19]
Mori  K,   Kondo   T,   Hangeshash    in-to       Randomized       control  n=44                        Cisplatin plus irinotecan             Decreased     adverse   effects  of
Kamiyama    Y,  Kano                              study                                                                                       chemotherapy-    induced  diarrhea
Y, Tominaga   K  [20]
*As assessed   by quality of life scale of European Organization  for Research   on treatment  of Cancer
**As assessed   by the Karnofsky  score
1.  Institute of Medicine (2003) Exploring complementary and alternative medicine.
In: The Richard and Hinda Rosenthal Lectures 2001.  The National Academies Press 26.  2.
Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, et al.
(2005) Use of complementary and alternative medicine in cancer patients: a European survey.
Ann Oncol 16: 655-663.  3.
Metz J, Jones H, Devine P, Hahn S, Glatstein E (2001) Cancer patients use unconventional medical
therapies far more frequently than standard history and physical examination suggest.
Cancer J 7: 149-154.  4.
Schofield PE, Juraskova I, Butow PN (2003) How oncologists discuss complementary therapy use with
their patients: an audio-tape audit.
Support Care Cancer 11: 348-355.  5.
Newell S, Sanson-Fisher RW (2000) Australian oncologists' self-reported knowledge and attitudes
about non-traditional therapies used by cancer patients.
Med J Aust 172: 110-113.
